美国睡眠外科医生阿片类药物处方趋势
该研究基于CMS part D数据库回顾性分析2013至2021年82名美国睡眠外科医生的阿片类药物处方趋势,发现阿片类药物索赔数、受益人数及每受益人供应天数均无显著变化,每受益人阿片类药物费用显著年降,2000年前完成住院医师培训者处方量显著高于2000年后完成者。
要点
- 2013至2021年睡眠外科医生阿片类药物索赔数和受益人数无显著变化。
- 2000年前完成住院医师培训者每受益人供应天数13.34天 vs 2000年后7.42天(p<0.001)。
- 每受益人阿片类药物费用呈显著年降(ANOVA,p=0.006)。
核心结论
- 睡眠外科医生阿片类药物处方从2013年至2021年保持稳定,未随其他耳鼻咽喉亚专科下降趋势而减少。
- 执业年限对阿片类药物处方趋势有显著影响,2000年前完成住院医师培训者处方量更高。
- 每受益人阿片类药物费用呈显著年降趋势。
研究设计与样本
- 回顾性分析,使用公开可得的CMS part D数据库,纳入82名美国睡眠外科医生,时间跨度为2013年至2021年。
- 统计分析采用ANOVA、t检验、Fisher精确检验(蒙特卡洛模拟)及回归模型。
主要发现
- 阿片类药物索赔数随时间无显著变化(p=0.782),每提供者受益人数无显著变化(p=0.590),每受益人阿片类药物供应天数无下降(p=0.489)。
- 2000年前完成住院医师培训者 vs 2000年后完成者:每受益人阿片类药物供应天数13.34 vs 7.42(p<0.001),每提供者阿片类药物受益人数21.62 vs 19.36(p=0.028),每提供者阿片类药物索赔数30.30 vs 21.78(p<0.001)。
- 每受益人阿片类药物费用呈显著年降(ANOVA,p=0.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to describe trends in opioid prescriptions among US sleep surgeons between 2013 and 2021 via a retrospective analysis conducted using publicly available data. METHODS: Utilizing the CMS part D database, we analyzed data from 82 sleep surgeons, focusing on metrics including number of opioid beneficiaries and claims, opioid cost, and opioid day supply per beneficiary. We employed statistical methods including ANOVA, t-tests, Fisher's exact test with Monte Carlo Simulation, and regression models. RESULTS: There were no significant changes in the number of opioid claims (p = 0.782) or beneficiaries per provider (p = 0.590) nor was there a decrease in opioid day supply per beneficiary (p = 0.489) over time. Surgeons who graduated residency before 2000 prescribed significantly more opioids over the course of the study period compared to those graduating after 2000 with higher opioid day supply per beneficiary (13.34 vs. 7.42, p < 0.001), higher opioid beneficiaries per provider (21.62 vs. 19.36, p = 0.028), and higher opioid claims per provider (30.30 vs. 21.78, p < 0.001). A significant annual decrease in opioid cost per beneficiary (ANOVA, p = 0.006) was noted. CONCLUSIONS: This study illuminates a significant impact of provider years in practice on opioid prescribing trends, alongside a decreasing trend in opioid cost per beneficiary. Despite the evolving paradigm emphasizing opioid reduction and evidence of decreasing opioid prescriptions in other otolaryngology subspecialties, our findings depict that opioid prescriptions among sleep surgeons remained stable from 2013 to 2021. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:4810-4817, 2024.
引用
- Saroya J, Singh A, Chang JL, et al. Opioid Prescription Trends Among Sleep Surgeons in the United States. Laryngoscope. 2024. PMID: 38877817. doi:10.1002/lary.31543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。